US OptionsDetailed Quotes
NVNO241115C5000
- 0.05
- 0.000.00%
15min DelayClose Nov 1 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume423 Open Interest5.00Strike Price0.00Turnover152.22%IV50.75%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1161Delta0.1965Gamma67.00Leverage Ratio-0.0069Theta0.0001Rho7.78Eff Leverage0.0013Vega
enVVeno Medical Stock Discussion
7 MINUTES AGO, 8:30 AM EDT
VIA ACCESSWIRE
First wave of implants successfully completed with updated delivery system performing very well
Company on schedule to be in position to apply for approval for enVVe pivotal trial mid-2025
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public OfferingenVVeno Medical (NASDAQ:NVNO) has announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock (or pre-funded warrants) at $3.50 per share. The company expects to receive gross proceeds of approximately $15.0 millionfrom the offering, excluding underwriting discounts and other expenses. The offering is expected to close around September 30, 2024.
The co...
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
enVVeno Medical has made significant progress in its FDA premarket approval (PMA) application for the VenoValve, a surgical replacement venous valve. The company has successfully submitted, and the FDA has approved, four out of five modules required for the PMA application. The fifth and final module, containing clinical data from the SAVVE U.S. pivotal trial, is expecte...
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical announced the presentation of new interim venous ulcer healing data from the VenoValve U.S. pivotal trial at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024. The data, presented by Dr. Cassius Iyad Ochoa Chaar of Yale School of Medici...
No comment yet